Ingredient research
What a compound does, dosage, timing, interactions, evidence. Very high volume, entirely informational, and the ground where a brand can build authority without making a claim it cannot make.
Regulated industry
Supplement marketing that survives its own claims
The thing that gets supplement ads rejected is almost never the product. It is one sentence of copy that turned a food into a drug, and it is usually the sentence the founder likes most. On the accounts seen here, rejections traced to claim language, and the same brands had no reorder programme despite selling a consumable that runs out on a schedule. Both fixable, both usually untouched.
Or call +1 (510) 312-5086 Mon to Sat, 9:00 to 18:00 ET
Free, written by a person, yours to keep either way.
Certified across the platforms we buy on. 150+ businesses, 7 years.
Marketing does not behave the same way here.
A supplement is regulated as a food rather than as a drug, and the moment your copy says it treats, prevents or cures anything, you have described a drug that has not been approved. That is the line the FDA polices and the FTC enforces against, and it is also the line the ad platforms use. Meta additionally restricts advertising that implies negative self-perception or promises a specific body outcome, which catches a large amount of standard weight and fitness creative. Google restricts specific ingredients outright.
None of this is arbitrary and all of it is survivable. It means copy is a compliance surface rather than a creative one, and the review has to happen before the spend rather than after the rejection.
The second thing that makes this category distinctive is much happier. You sell a consumable with a known duration. A customer who bought a 60-day supply will need more in roughly 60 days, and you know that. A large share of brands do nothing with it, run no reorder timing, and go on buying the same customer again through paid social at full price.
How your customers actually search.
Best for a goal
Best supplement for a specific outcome. Buying intent, competitive, and held largely by affiliate and publisher content rather than by brands.
Safety and side effects
Side effects, interactions with medication, whether it is safe alongside a condition someone already has. These get typed into Google before an order and tend to be answered nowhere on the site selling the product.
Brand and comparison
Brand against brand, reviews, third-party testing. Where the purchase decision is finalised, and where testing documentation earns its keep.
How an enquiry becomes a customer.
Different intents take different routes. Serving all of them with one page is the most common structural mistake in this industry.
- Ingredient or goal research, usually several sessions before any brand is considered.
- Safety and evidence checking, which is the step that stops cautious buyers and is rarely addressed on site.
- First purchase, often a single unit as a trial rather than the bundle the brand wants to sell.
- Reorder at the point the supply runs out, which is predictable, and which is where the profit in the category actually is.
- Disease claims in product copy, title tags and meta descriptions, which is both a regulatory exposure and the reason ads get rejected.
- No ingredient content at all, which is the largest and least competitive body of search demand available to the brand.
- Nothing written on side effects or interactions, so the cautious buyer leaves to find it elsewhere and buys there instead.
- Third-party testing mentioned but never documented, when it is the strongest differentiator most brands have.
- Product pages that vary only by flavour, generating near-duplicate content across the catalogue.
- A claim review of every live asset before spend, which heads off the rejections and account restrictions this category collects.
- Creative built to avoid the personal attributes and body-outcome policies, which is a structural constraint rather than a copywriting preference.
- Search campaigns on ingredient and category terms, where intent is clear and policy risk is far lower than on outcome-led social creative.
- Allowable cost set against the second and third order rather than the first, because the reorder is where the margin is.
- Reorder timing based on the actual supply purchased, which is the single highest-return automation available and is usually missing entirely.
- Subscription conversion after a successful first cycle, offered when the product has had time to be judged rather than at checkout.
- Education sequences on ingredients and usage, which improve adherence, and a customer who takes the product properly is the one who reorders.
- Win-back timed to the point a lapsed customer would have run out, rather than to a generic 90-day rule.
What the report should lead with.
- Repeat purchase rate and average time to reorder
- Subscription take-up and retention at cycle three
- Contribution margin after discounts and shipping, not revenue
- Ad account policy rejections, which should trend to zero
- Non-brand organic clicks to ingredient and education content
Proof
Numbers from comparable accounts.
SEO
470K
organic clicks in 12 months
21.3M impressions at an average position of 8.8.
Real accounts, anonymised by client agreement. Currency as recorded in the account. Movement varies by market, budget and starting position.
On camera
Four clients on camera, in their own words.
Four clients, four industries, one thing in common: the number moved and they said so on camera.
-
It is the best long-term investment we have made in the company, full stop.
Ahmed · Business owner · SEO
-
The cost per lead from organic is a fraction of what we pay on ads, and that math gets better every month.
Sandra · Founder · SEO
-
People can book a table without calling during the dinner rush. My host actually thanked me.
Aaliyah · Restaurant owner · Website
-
These tech geeks know the Facebook analytics and the data and the pixels and all that stuff that makes a musician’s head explode.
David · The Wankers · Social ads
Read next, if you run a business like this.
What Gmail, Yahoo and Outlook now require from bulk senders
The authentication, unsubscribe and spam rate rules Google, Yahoo and Microsoft publish for senders, the dates each took effect, and what missing one costs.
Read the post
How to advertise CBD online in 2026 without losing your ad account
What Google and Meta actually permit for CBD and hemp, which products qualify, and the channel mix that keeps working when a platform review goes against you.
Read the postEmail marketing ROI: why $36 to $1 is not your number, and what it actually costs to run
Where the $36 back for every $1 figure comes from, what email really costs at 5,000 contacts, and how to work out your own return.
Read the postQuestions
Questions from this industry.
01 Why do our supplement Facebook ads keep getting rejected?
Usually the copy rather than the product. Meta restricts advertising that implies negative self-perception or promises a specific body outcome, and separately anything reading as a health claim runs into the same rules the FDA applies. It is fixable, and it is fixed before the spend rather than by appealing afterwards.
02 What can a supplement brand actually say about its product?
A great deal. Structure and function statements are permitted, so you can describe what an ingredient does in the body. What you cannot do is say it treats, prevents or cures a condition. Most brands underuse the permitted range because they are preoccupied with the one sentence they cannot have.
03 Is supplement SEO realistic against the big publisher sites?
Not for best-of listicles, which are theirs. Ingredient depth, dosage, timing, interactions and safety are a different matter, and brands are usually better placed to write those than publishers are. It is a slower route, and it is the one that does not stop working when an ad account gets restricted.
04 We spend everything on getting new customers. Is that wrong?
It is expensive. You sell a product that runs out on a schedule you know, which makes reorder timing the cheapest revenue in the business. Brands that fix the reorder first can afford to pay more for new customers afterwards, which is usually the order these things should happen in.